Ablative Therapy
Showing 1 - 25 of >10,000
Prostate Cancer, Oligoprogressive, Urothelial Carcinoma Trial in Sacramento (Ablative local therapy)
Recruiting
- Prostate Cancer
- +3 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 19, 2023
Breast Cancer, Oligoprogressive, Head Neck Cancer Trial in Sacramento (Ablative local therapy)
Recruiting
- Breast Cancer
- +4 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 19, 2023
NSCLC, Oligoprogressive, Small-cell Lung Cancer Trial in Sacramento (Ablative local therapy)
Recruiting
- Non-small Cell Lung Cancer
- +2 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 27, 2023
Esophageal Cancer, Small Bowel Cancer, Gastroesophageal-junction Cancer Trial in Sacramento (Ablative local therapy)
Recruiting
- Esophageal Cancer
- +10 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 27, 2023
Immunophenotyping in Metastatic Kidney Cancer Patients Receiving
Recruiting
- Metastatic Renal Cell Carcinoma
- Stage IV Renal Cell Cancer AJCC v8
- Biospecimen Collection
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 6, 2023
Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 Trial (Stereotactic Ablative Radiotherapy, Resection,
Not yet recruiting
- Metastatic Colorectal Adenocarcinoma
- Stage IV Colorectal Cancer AJCC v8
- Stereotactic Ablative Radiotherapy
- +6 more
- (no location specified)
Dec 21, 2022
Colorectal Cancer, Oligometastatic Disease Trial in Australia (Local Ablative Therapy, Standard first-line systemic treatment)
Recruiting
- Colorectal Cancer
- Oligometastatic Disease
- Local Ablative Therapy
- Standard first-line systemic treatment
-
Albury, New South Wales, Australia
- +8 more
May 15, 2023
Lung Adenocarcinoma, Lung Tumors Trial run by the NCI (osimertinib, LAT)
Completed
- Lung Adenocarcinoma
- Lung Neoplasms
- osimertinib
- LAT
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 17, 2022
Breast Cancer Invasive, Metastatic Cancer, Oligoprogressive Trial in Amsterdam (procedure, radiation, other)
Not yet recruiting
- Breast Cancer Invasive
- +2 more
- Surgery
- +2 more
-
Amsterdam, NetherlandsAntoni van Leeuwenhoek
Mar 21, 2022
Prostate Cancer Trial in Dallas (Ablative Therapy)
Not yet recruiting
- Prostate Cancer
- Ablative Therapy
-
Dallas, TexasUTSW
Jul 25, 2022
NSCLC, Metastatic Non Small Cell Lung Cancer, Nsclc Trial in United States (Local ablative therapy, Blood collection to assess
Recruiting
- Non-small Cell Lung Cancer
- +5 more
- Local ablative therapy
- Blood collection to assess for ctDNA
-
Basking Ridge, New Jersey
- +6 more
Jun 20, 2022
Brain Metastases, Adult Trial in Leuven (Stereotactic radiotherapy)
Recruiting
- Brain Metastases, Adult
- Stereotactic radiotherapy
-
Leuven, BelgiumUZLeuven
Oct 21, 2021
Large B-cell Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Tampa (Comprehensive Ablative Bridging Irradiation (CABI),
Recruiting
- Large B-cell Lymphoma
- Relapsed Non-Hodgkin Lymphoma
- Comprehensive Ablative Bridging Irradiation (CABI)
- Chimeric Antigen Receptor T-Cell Therapy
-
Tampa, FloridaMoffitt Cancer Center
Oct 26, 2023
NSCLC (NSCLC), Stage IV Trial in Switzerland (Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy),
Not yet recruiting
- Non-small Cell Lung Cancer (NSCLC)
- Stage IV
- Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy)
- +2 more
-
Aarau, Switzerland
- +7 more
Oct 27, 2023
Emphysema Trial in Palo Alto (Stereotactic Ablative Radiotherapy (SABR))
Recruiting
- Emphysema
- Stereotactic Ablative Radiotherapy (SABR)
-
Palo Alto, CaliforniaStanford Cancer Center
Oct 24, 2022
Prostate Cancer Metastatic Trial in Canada (Ablative Radiation Therapy, Standard of care)
Recruiting
- Prostate Cancer Metastatic
- Ablative Radiation Therapy
- Standard of care
-
Victoria, British Columbia, Canada
- +14 more
Nov 14, 2022
Pancreatic Cancer Trial (MRIdian)
Not yet recruiting
- Pancreatic Cancer
- MRIdian
- (no location specified)
Oct 14, 2022
Malignant Prostate Tumor Trial in Rochester (procedure, radiation, other)
Not yet recruiting
- Malignant Prostate Neoplasm
- Computed Tomography
- +5 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Apr 13, 2023
Lung Metastases, Colorectal Cancer Metastatic Trial in Amsterdam (Minimally invasive pulmonary metastasectomy, Stereotactic
Not yet recruiting
- Lung Metastases
- Colorectal Cancer Metastatic
- Minimally invasive pulmonary metastasectomy
- Stereotactic ablative radiotherapy
-
Amsterdam, NetherlandsAmsterdam University Medical Center (AUMC)
Apr 10, 2023
Actinic Keratosis, Sun Damaged Skin, Solar Keratosis Trial (Ablative Fractional Carbon Dioxide (CO2) Laser, Microdermabrasion)
Completed
- Actinic Keratosis
- +3 more
- Ablative Fractional Carbon Dioxide (CO2) Laser
- Microdermabrasion
- (no location specified)
Sep 13, 2022
Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Cairo (radiation, procedure, other)
Recruiting
- Breast Cancer
- +2 more
- Stereotactic Ablative Radiation Therapy
- +2 more
-
Cairo, EgyptNational Cancer Institute
Nov 20, 2023
Metastatic Clear Cell Renal Cell Carcinoma Trial in Dallas (Nivolumab, SAbR)
Terminated
- Metastatic Clear Cell Renal Cell Carcinoma
- Nivolumab
- SAbR
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Jul 12, 2022
Oligoprogressive Renal Cell Carcinoma Trial in Dallas (Stereotactic ablative body radiation (SABR))
Active, not recruiting
- Oligoprogressive Renal Cell Carcinoma
- Stereotactic ablative body radiation (SABR)
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Nov 28, 2022
Metastatic Tumor Trial in Prince George, London, Montréal (radiation, drug, other, procedure)
Not yet recruiting
- Metastatic Tumor
- Palliative Radiotherapy
- +9 more
-
Prince George, British Columbia, Canada
- +2 more
Feb 6, 2023
Locally Advanced Pancreatic Cancer Trial in Washington, Baltimore (Gemcitabine, Hypofractionated Ablative Proton Therapy)
Recruiting
- Locally Advanced Pancreatic Cancer
- Gemcitabine
- Hypofractionated Ablative Proton Therapy
-
Washington, District of Columbia
- +1 more
Oct 10, 2022